The European Commission has granted full licensure to Merck’s VSV-ZEBOV, Ebola vaccine, a first for the product, which is currently being used in the Ebola outbreak in the Democratic Republic of the Congo (DRC).

“This is great news: @EU_Commission approved licensing the rVSV-ZEBOV-GP Ebola vaccine, the first time an Ebola vaccine has been licensed anywhere in the world,” tweeted World Health Organization (WHO) Director-General Tedros Adhanom Ghebreysus, PhD, today. “I am proud of the dedication & collaboration of all involved. Next step is WHO prequalification, expected within days.”

Credit: National Institute of Allergy and Infectious Diseases (NIAID)

Read more at CIDRAP…